CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on July 31, 2019
Aethlon Medical, Inc.
9365 Granite Ridge Drive, Suite 100
San Diego, California 92123
August 1, 2019
Via Edgar
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Thomas Jones |
| Tim Buchmiller | |
| Re: | Aethlon Medical, Inc. (the “Company”) |
| Registration Statement on Form S-3 (File No. 333-231397) | |
| Acceleration Request | |
| Requested Date: | August 1, 2019 | |
| Requested Time: | 1:00 P.M. Eastern Time |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 1:00 P.M. Eastern Time on August 1, 2019 or as soon thereafter as is practicable.
If you have any questions regarding this request, please contact Julie Robinson of Cooley LLP at (858) 550-6092.
Very truly yours,
Aethlon medical, Inc.
/s/ James B. Frakes
James B. Frakes
Chief Financial Officer